Paternal age effect mutations and selfish spermatogonial selection: causes and consequences for human disease.
暂无分享,去创建一个
[1] P. Burfeind,et al. CHD7 mutations causing CHARGE syndrome are predominantly of paternal origin , 2012, Clinical genetics.
[2] Qi Xu,et al. Common variants on 8p12 and 1q24.2 confer risk of schizophrenia , 2011, Nature Genetics.
[3] L. Vissers,et al. De novo copy number variants associated with intellectual disability have a paternal origin and age bias , 2011, Journal of Medical Genetics.
[4] S. Lok,et al. Increased exonic de novo mutation rate in individuals with schizophrenia , 2011, Nature Genetics.
[5] A. Wilkie,et al. OCT2, SSX and SAGE1 reveal the phenotypic heterogeneity of spermatocytic seminoma reflecting distinct subpopulations of spermatogonia , 2011, The Journal of pathology.
[6] S. Levy,et al. Exome sequencing supports a de novo mutational paradigm for schizophrenia , 2011, Nature Genetics.
[7] M. DePristo,et al. Variation in genome-wide mutation rates within and between human families , 2011, Nature Genetics.
[8] Boris Yamrom,et al. Rare De Novo and Transmitted Copy-Number Variation in Autistic Spectrum Disorders , 2011, Neuron.
[9] Michael Wigler,et al. Rare De Novo Variants Associated with Autism Implicate a Large Functional Network of Genes Involved in Formation and Function of Synapses , 2011, Neuron.
[10] M. Rieder,et al. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations , 2011, Nature Genetics.
[11] R. Tenconi,et al. Phenotypic analysis of individuals with Costello syndrome due to HRAS p.G13C , 2011, American journal of medical genetics. Part A.
[12] A. Barrett,et al. New aids for the non‐invasive prenatal diagnosis of achondroplasia: dysmorphic features, charts of fetal size and molecular confirmation using cell‐free fetal DNA in maternal plasma , 2011, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[13] B. Neel,et al. MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1(L613V) mutation. , 2011, The Journal of clinical investigation.
[14] G. Cote,et al. Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation. , 2011, Thyroid : official journal of the American Thyroid Association.
[15] Stephen R Quake,et al. Whole-genome molecular haplotyping of single cells , 2011, Nature Biotechnology.
[16] A. Buja,et al. RareDeNovoandTransmittedCopy-NumberVariation in Autistic Spectrum Disorders , 2011 .
[17] L. Petersen,et al. Paternal age at birth of first child and risk of schizophrenia. , 2011, The American journal of psychiatry.
[18] S. Y. Park,et al. Non-invasive prenatal detection of achondroplasia using circulating fetal DNA in maternal plasma , 2011, Journal of Assisted Reproduction and Genetics.
[19] J. Seidman,et al. Activation of multiple signaling pathways causes developmental defects in mice with a Noonan syndrome–associated Sos1 mutation. , 2010, The Journal of clinical investigation.
[20] Christian Gilissen,et al. A de novo paradigm for mental retardation , 2010, Nature Genetics.
[21] Deborah A Nickerson,et al. De novo rates and selection of large copy number variation. , 2010, Genome research.
[22] D. Altshuler,et al. A map of human genome variation from population-scale sequencing , 2010, Nature.
[23] Alexander R. Griffing,et al. Direct measure of the de novo mutation rate in autism and schizophrenia cohorts. , 2010, American journal of human genetics.
[24] Allon M. Klein,et al. Mouse germ line stem cells undergo rapid and stochastic turnover. , 2010, Cell stem cell.
[25] A. Kozubík,et al. FGFR3 signaling induces a reversible senescence phenotype in chondrocytes similar to oncogene-induced premature senescence , 2010 .
[26] A. Wilkie,et al. Missing heritability: paternal age effect mutations and selfish spermatogonia , 2010, Nature Reviews Genetics.
[27] Gary D Bader,et al. Functional impact of global rare copy number variation in autism spectrum disorders , 2010, Nature.
[28] H. Firth,et al. Germline and somatic mosaicism for FGFR2 mutation in the mother of a child with Crouzon syndrome: Implications for genetic testing in “paternal age-effect” syndromes , 2010, American journal of medical genetics. Part A.
[29] Alan Hodgkinson,et al. The Genomic Distribution and Local Context of Coincident SNPs in Human and Chimpanzee , 2010, Genome biology and evolution.
[30] A. Kozubík,et al. FGFR3 signaling induces a reversible senescence phenotype in chondrocytes similar to oncogene-induced premature senescence. , 2010, Bone.
[31] Zhixian Yang,et al. Analysis of SCN1A mutation and parental origin in patients with Dravet syndrome , 2010, Journal of Human Genetics.
[32] J. Lupski,et al. Mechanisms for nonrecurrent genomic rearrangements associated with CMT1A or HNPP: rare CNVs as a cause for missing heritability. , 2010, American journal of human genetics.
[33] Paolo Vineis,et al. A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer , 2010, Nature Genetics.
[34] Wolfgang Schulze,et al. Screening for biomarkers of spermatogonia within the human testis: a whole genome approach. , 2010, Human reproduction.
[35] P. Shannon,et al. Analysis of Genetic Inheritance in a Family Quartet by Whole-Genome Sequencing , 2010, Science.
[36] Fyodor A Kondrashov,et al. Measurements of spontaneous rates of mutations in the recent past and the near future , 2010, Philosophical Transactions of the Royal Society B: Biological Sciences.
[37] D. Cyr,et al. Surfing the wave, cycle, life history, and genes/proteins expressed by testicular germ cells. Part 1: Background to spermatogenesis, spermatogonia, and spermatocytes , 2010, Microscopy research and technique.
[38] J. Kere,et al. Genomic landscape of positive natural selection in Northern European populations , 2010, European Journal of Human Genetics.
[39] X. Bao,et al. Analysis of the Parental Origin of De Novo MECP2 Mutations and X Chromosome Inactivation in 24 Sporadic Patients With Rett Syndrome in China , 2010, Journal of child neurology.
[40] A. Olshan,et al. Association of paternal age and risk for major congenital anomalies from the National Birth Defects Prevention Study, 1997 to 2004. , 2010, Annals of epidemiology.
[41] Deborah L. Levy,et al. A recurrent 16p12.1 microdeletion suggests a two-hit model for severe developmental delay , 2010, Nature Genetics.
[42] F. Raue,et al. Update multiple endocrine neoplasia type 2 , 2010, Familial Cancer.
[43] B. Gelb,et al. Noonan Syndrome: Clinical Aspects and Molecular Pathogenesis , 2010, Molecular Syndromology.
[44] M. Lynch. Rate, molecular spectrum, and consequences of human mutation , 2010, Proceedings of the National Academy of Sciences.
[45] S. Turner,et al. Real-time DNA sequencing from single polymerase molecules. , 2010, Methods in enzymology.
[46] S. Kéri,et al. Neuregulin 1-stimulated phosphorylation of AKT in psychotic disorders and its relationship with neurocognitive functions , 2009, Neurochemistry International.
[47] P. Hunt,et al. Maternal age and chromosomally abnormal pregnancies: what we know and what we wish we knew , 2009, Current opinion in pediatrics.
[48] L. Croen,et al. Risk of autism and increasing maternal and paternal age in a large north American population. , 2009, American journal of epidemiology.
[49] G. McVean,et al. Activating mutations in FGFR3 and HRAS reveal a shared genetic origin for congenital disorders and testicular tumors , 2009, Nature Genetics.
[50] Judy H. Cho,et al. Finding the missing heritability of complex diseases , 2009, Nature.
[51] S. Sommer,et al. Analysis of Cancer Mutation Signatures in Blood by a Novel Ultra-Sensitive Assay: Monitoring of Therapy or Recurrence in Non-Metastatic Breast Cancer , 2009, PloS one.
[52] Xin Duan,et al. DISC1 Regulates New Neuron Development in the Adult Brain via Modulation of AKT-mTOR Signaling through KIAA1212 , 2009, Neuron.
[53] M. Hurles,et al. Copy number variation in human health, disease, and evolution. , 2009, Annual review of genomics and human genetics.
[54] J. Lupski,et al. Mechanisms of change in gene copy number , 2009, Nature Reviews Genetics.
[55] B. Ng,et al. De novo apparently balanced translocations in man are predominantly paternal in origin and associated with a significant increase in paternal age , 2009, Journal of Medical Genetics.
[56] I. Scheffer,et al. De novo SCN1A mutations in Dravet syndrome and related epileptic encephalopathies are largely of paternal origin , 2009, Journal of Medical Genetics.
[57] M. Oshimura,et al. Genetic reconstruction of mouse spermatogonial stem cell self-renewal in vitro by Ras-cyclin D2 activation. , 2009, Cell stem cell.
[58] Rivka L. Glaser,et al. The Ups and Downs of Mutation Frequencies during Aging Can Account for the Apert Syndrome Paternal Age Effect , 2009, PLoS genetics.
[59] A. Munnich,et al. Thanatophoric dysplasia caused by double missense FGFR3 mutations , 2009, American journal of medical genetics. Part A.
[60] Xin Zhou,et al. Multiplex fluorescent PCR for noninvasive prenatal detection of fetal-derived paternally inherited diseases using circulatory fetal DNA in maternal plasma. , 2009, European journal of obstetrics, gynecology, and reproductive biology.
[61] M. Tartaglia,et al. Craniosynostosis in patients with Noonan syndrome caused by germline KRAS mutations , 2009, American journal of medical genetics. Part A.
[62] P. Hurlin,et al. The role of senescence and prosurvival signaling in controlling the oncogenic activity of FGFR2 mutants associated with cancer and birth defects , 2009, Human molecular genetics.
[63] S. Warren,et al. Replication stress induces genome-wide copy number changes in human cells that resemble polymorphic and pathogenic variants. , 2009, American journal of human genetics.
[64] G. Rosenberger,et al. Oncogenic HRAS mutations cause prolonged PI3K signaling in response to epidermal growth factor in fibroblasts of patients with Costello syndrome , 2009, Human mutation.
[65] A. Barnett,et al. Advanced Paternal Age Is Associated with Impaired Neurocognitive Outcomes during Infancy and Childhood , 2009, PLoS medicine.
[66] S. Saitta,et al. MAP'ing CNS Development and Cognition: An ERKsome Process , 2009, Neuron.
[67] M C O'Donovan,et al. Analysis of 10 independent samples provides evidence for association between schizophrenia and a SNP flanking fibroblast growth factor receptor 2 , 2009, Molecular Psychiatry.
[68] S. Turner,et al. Real-Time DNA Sequencing from Single Polymerase Molecules , 2009, Science.
[69] Russell S. Kirby,et al. Advanced Parental Age and the Risk of Autism Spectrum Disorder , 2008, American journal of epidemiology.
[70] Y. Elgersma,et al. Oncogenes on my mind: ERK and MTOR signaling in cognitive diseases. , 2008, Trends in genetics : TIG.
[71] H. Matsuzaki,et al. Paternal age at birth and high-functioning autistic-spectrum disorder in offspring , 2008, British Journal of Psychiatry.
[72] G. Shaw,et al. The population‐based prevalence of achondroplasia and thanatophoric dysplasia in selected regions of the US , 2008, American journal of medical genetics. Part A.
[73] Kun Chen,et al. Association between H-RAS T81C genetic polymorphism and gastrointestinal cancer risk: A population based case-control study in China , 2008, BMC Cancer.
[74] C. Hultman,et al. Advancing paternal age and bipolar disorder. , 2008, Archives of general psychiatry.
[75] Y. Matsubara,et al. The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders , 2008, Human mutation.
[76] Christopher Y. Park,et al. Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects , 2008, Nature Genetics.
[77] N. Arnheim,et al. A germ-line-selective advantage rather than an increased mutation rate can explain some unexpectedly common human disease mutations , 2008, Proceedings of the National Academy of Sciences.
[78] C. Amos,et al. Relative effects of mutability and selection on single nucleotide polymorphisms in transcribed regions of the human genome , 2008, BMC Genomics.
[79] Y. Giudicelli,et al. Increased achondroplasia mutation frequency with advanced age and evidence for G1138A mosaicism in human testis biopsies. , 2008, Fertility and sterility.
[80] D. Krewski,et al. Paternal age and adverse birth outcomes: teenager or 40+, who is at risk? , 2008, Human reproduction.
[81] H. Toriello,et al. Statement on guidance for genetic counseling in advanced paternal age , 2008, Genetics in Medicine.
[82] Joseph A. Gogos,et al. Strong association of de novo copy number mutations with sporadic schizophrenia , 2008, Nature Genetics.
[83] S. Krajewski,et al. Development of diabesity in mice with neuronal deletion of Shp2 tyrosine phosphatase. , 2008, The American journal of pathology.
[84] Julian Parkhill,et al. Single-cell genomics , 2008, Nature Reviews Microbiology.
[85] E. Moreno. Is cell competition relevant to cancer? , 2008, Nature Reviews Cancer.
[86] D. Horn,et al. Mutation and phenotypic spectrum in patients with cardio‐facio‐cutaneous and Costello syndrome , 2007, Clinical genetics.
[87] N. Carter,et al. Germline rates of de novo meiotic deletions and duplications causing several genomic disorders , 2008, Nature Genetics.
[88] J. Lupski,et al. A DNA Replication Mechanism for Generating Nonrecurrent Rearrangements Associated with Genomic Disorders , 2007, Cell.
[89] G. De Backer,et al. Paternal age at birth is an important determinant of offspring telomere length. , 2007, Human molecular genetics.
[90] Kyle Summers,et al. Adaptive evolution of genes underlying schizophrenia , 2007, Proceedings of the Royal Society B: Biological Sciences.
[91] E. Spector,et al. Familial acanthosis nigricans due to K650T FGFR3 mutation. , 2007, Archives of dermatology.
[92] R. Brinster,et al. Glial Cell Line-derived Neurotrophic Factor Regulation of Genes Essential for Self-renewal of Mouse Spermatogonial Stem Cells Is Dependent on Src Family Kinase Signaling* , 2007, Journal of Biological Chemistry.
[93] N. Arnheim,et al. The Molecular Anatomy of Spontaneous Germline Mutations in Human Testes , 2007, PLoS biology.
[94] X. Coumoul,et al. RNA interference and inhibition of MEK-ERK signaling prevent abnormal skeletal phenotypes in a mouse model of craniosynostosis , 2007, Nature Genetics.
[95] F. Real,et al. Spectrum of FGFR3 mutations in multiple intraindividual seborrheic keratoses. , 2007, The Journal of investigative dermatology.
[96] N. Skakkebaek,et al. Preserved fertility in a non-mosaic Klinefelter patient with a mutation in the fibroblast growth factor receptor 3 gene: case report. , 2007, Human reproduction.
[97] A. Molven,et al. De novo HRAS and KRAS mutations in two siblings with short stature and neuro-cardio-facio-cutaneous features , 2007, Journal of Medical Genetics.
[98] Lester L. Peters,et al. Genome-wide association study identifies novel breast cancer susceptibility loci , 2007, Nature.
[99] W. Willett,et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer , 2007, Nature Genetics.
[100] S. Toyokuni,et al. Akt mediates self-renewal division of mouse spermatogonial stem cells , 2007, Development.
[101] M. Ahmadian,et al. Myopathy caused by HRAS germline mutations: implications for disturbed myogenic differentiation in the presence of constitutive HRas activation , 2007, Journal of Medical Genetics.
[102] Claudio Carta,et al. Diversity, parental germline origin, and phenotypic spectrum of de novo HRAS missense changes in Costello syndrome , 2007, Human mutation.
[103] A. Wilkie,et al. Clinical hypochondroplasia in a family caused by a heterozygous double mutation in FGFR3 encoding GLY380LYS , 2007, American journal of medical genetics. Part A.
[104] Y. Nabeshima,et al. Functional identification of the actual and potential stem cell compartments in mouse spermatogenesis. , 2007, Developmental cell.
[105] E. Rajpert-De Meyts. Recent advances and future directions in research on testicular germ cell cancer. , 2007, International journal of andrology.
[106] K. Czene,et al. Parental age and risk of childhood cancers: a population-based cohort study from Sweden. , 2006, International journal of epidemiology.
[107] J. Hoffman,et al. Somatic mosaicism for an HRAS mutation causes Costello syndrome , 2006, American journal of medical genetics. Part A.
[108] G. Davey Smith,et al. Advanced paternal age: How old is too old? , 2006, Journal of Epidemiology and Community Health.
[109] J. Böhm,et al. SALL1 mutations in sporadic Townes–Brocks syndrome are of predominantly paternal origin without obvious paternal age effect , 2006, American journal of medical genetics. Part A.
[110] Michael Lachmann,et al. Evolution of primate gene expression , 2006, Nature Reviews Genetics.
[111] K. Gripp,et al. Paternal bias in parental origin of HRAS mutations in Costello syndrome , 2006, Human mutation.
[112] A. Balmain,et al. A functional switch from lung cancer resistance to susceptibility at the Pas1 locus in Kras2LA2 mice , 2006, Nature Genetics.
[113] T. Abraham,et al. Influence of single nucleotide polymorphisms in H-Ras and cyclin D1 genes on oral cancer susceptibility. , 2006, Oral oncology.
[114] H. Brunner,et al. The origin of EFNB1 mutations in craniofrontonasal syndrome: frequent somatic mosaicism and explanation of the paucity of carrier males. , 2006, American journal of human genetics.
[115] R. Hard,et al. Fibroblast growth factor receptor signaling affects development and function of dopamine neurons – inhibition results in a schizophrenia‐like syndrome in transgenic mice , 2006, Journal of neurochemistry.
[116] Vip Viprakasit,et al. A Regulatory SNP Causes a Human Genetic Disease by Creating a New Transcriptional Promoter , 2006, Science.
[117] Hans O Kalkman,et al. The role of the phosphatidylinositide 3-kinase-protein kinase B pathway in schizophrenia. , 2006, Pharmacology & therapeutics.
[118] Francesca Chiaromonte,et al. Strong and weak male mutation bias at different sites in the primate genomes: insights from the human-chimpanzee comparison. , 2006, Molecular biology and evolution.
[119] P. Rump,et al. Severe complications in a child with achondroplasia and two FGFR3 mutations on the same allele , 2006, American journal of medical genetics. Part A.
[120] W. Reardon,et al. Genotype-phenotype correlation in Costello syndrome: HRAS mutation analysis in 43 cases , 2005, Journal of Medical Genetics.
[121] J. Crow. Age and sex effects on human mutation rates: an old problem with new complexities. , 2006, Journal of radiation research.
[122] M. Knaap,et al. Propensity for paternal inheritance of de novo mutations in Alexander disease , 2006, Human Genetics.
[123] Pawel Stankiewicz,et al. Genomic Disorders: Molecular Mechanisms for Rearrangements and Conveyed Phenotypes , 2005, PLoS genetics.
[124] D. Noh,et al. Association of paternal age at birth and the risk of breast cancer in offspring: a case control study , 2005, BMC Cancer.
[125] K. Yutzey,et al. Noonan Syndrome Mutation Q79R in Shp2 Increases Proliferation of Valve Primordia Mesenchymal Cells via Extracellular Signal–Regulated Kinase 1/2 Signaling , 2005, Circulation research.
[126] Yukichi Tanaka,et al. Germline mutations in HRAS proto-oncogene cause Costello syndrome , 2005, Nature Genetics.
[127] A. Wilkie,et al. Fibroblast growth factor receptor 2, gain‐of‐function mutations, and tumourigenesis: investigating a potential link , 2005, The Journal of pathology.
[128] Timothy B Sackton,et al. A Scan for Positively Selected Genes in the Genomes of Humans and Chimpanzees , 2005, PLoS biology.
[129] G. McVean,et al. Gain-of-function amino acid substitutions drive positive selection of FGFR2 mutations in human spermatogonia , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[130] E. Grice,et al. A common sex-dependent mutation in a RET enhancer underlies Hirschsprung disease risk , 2005, Nature.
[131] A. Wilkie. Bad bones, absent smell, selfish testes: the pleiotropic consequences of human FGF receptor mutations. , 2005, Cytokine & growth factor reviews.
[132] Robert J. Linhardt,et al. Analysis of Mutations in Fibroblast Growth Factor (FGF) and a Pathogenic Mutation in FGF Receptor (FGFR) Provides Direct Evidence for the Symmetric Two-End Model for FGFR Dimerization , 2005, Molecular and Cellular Biology.
[133] Christine M. Malcom,et al. Accelerated Evolution of Nervous System Genes in the Origin of Homo sapiens , 2004, Cell.
[134] R. Brinster,et al. Growth factors essential for self-renewal and expansion of mouse spermatogonial stem cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[135] Nobuyuki Itoh,et al. Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggests distinct pathophysiological mechanisms for craniofacial and limb abnormalities. , 2004, Human molecular genetics.
[136] M. Patton,et al. Paternal germline origin and sex-ratio distortion in transmission of PTPN11 mutations in Noonan syndrome. , 2004, American journal of human genetics.
[137] K. Kinzler,et al. Cancer genes and the pathways they control , 2004, Nature Medicine.
[138] A. V. D. van den Ouweland,et al. Paternal origin of FGFR3 mutations in Muenke-type craniosynostosis , 2004, Human Genetics.
[139] Konrad Basler,et al. dMyc Transforms Cells into Super-Competitors , 2004, Cell.
[140] Rivka L. Glaser,et al. The paternal-age effect in Apert syndrome is due, in part, to the increased frequency of mutations in sperm. , 2003, American journal of human genetics.
[141] E. Jabs,et al. Parental origin of mutations in sporadic cases of Treacher Collins syndrome , 2003, European Journal of Human Genetics.
[142] G. McVean,et al. Evidence for Selective Advantage of Pathogenic FGFR2 Mutations in the Male Germ Line , 2003, Science.
[143] H. Ewald,et al. Parental age and risk of schizophrenia: a case-control study. , 2003, Archives of general psychiatry.
[144] Alexey S Kondrashov,et al. Direct estimates of human per nucleotide mutation rates at 20 loci causing mendelian diseases , 2003, Human mutation.
[145] J. Brockmöller,et al. A single nucleotide polymorphism in the human H-ras proto-oncogene determines the risk of urinary bladder cancer. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[146] N. Arnheim,et al. The observed human sperm mutation frequency cannot explain the achondroplasia paternal age effect , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[147] A. V. D. van den Ouweland,et al. FGFs, their receptors, and human limb malformations: clinical and molecular correlations. , 2002, American journal of medical genetics.
[148] P. Nowell. Tumor progression: a brief historical perspective. , 2002, Seminars in cancer biology.
[149] Kateryna D. Makova,et al. Strong male-driven evolution of DNA sequences in humans and apes , 2002, Nature.
[150] C. Fahim,et al. Paternal age and sporadic schizophrenia: evidence for de novo mutations. , 2002, American journal of medical genetics.
[151] E. Zackai,et al. Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis. , 2002, American journal of human genetics.
[152] A. Gavin,et al. Association of early life factors and acute lymphoblastic leukaemia in childhood: historical cohort study , 2002, British Journal of Cancer.
[153] P. V. van Diest,et al. Atypical MEN type 2B associated with two germline RET mutations on the same allele not involving codon 918. , 2002, The Journal of clinical endocrinology and metabolism.
[154] W. Foulkes,et al. Familial medullary thyroid carcinoma and prominent corneal nerves associated with the germline V804M and V778I mutations on the same allele of RET , 2001, Journal of medical genetics.
[155] P. Huppke,et al. MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin. , 2001, American journal of human genetics.
[156] M. Saarma,et al. Promotion of seminomatous tumors by targeted overexpression of glial cell line-derived neurotrophic factor in mouse testis. , 2001, Cancer research.
[157] J. Chelly,et al. Parental origin of de novo MECP2 mutations in Rett syndrome , 2001, European Journal of Human Genetics.
[158] L D Edmonds,et al. The National Birth Defects Prevention Study , 2001, Public health reports.
[159] D. Malaspina,et al. Paternal factors and schizophrenia risk: de novo mutations and imprinting. , 2001, Schizophrenia bulletin.
[160] S. Rosengren,et al. Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype. , 2000, American journal of human genetics.
[161] J. Crow. The origins, patterns and implications of human spontaneous mutation , 2000, Nature Reviews Genetics.
[162] M. Nachman,et al. Estimate of the mutation rate per nucleotide in humans. , 2000, Genetics.
[163] Rivka L. Glaser,et al. Paternal origin of FGFR2 mutations in sporadic cases of Crouzon syndrome and Pfeiffer syndrome. , 2000, American journal of human genetics.
[164] M. Saarma,et al. Regulation of cell fate decision of undifferentiated spermatogonia by GDNF. , 2000, Science.
[165] M. Ichihara,et al. A two-hit model for development of multiple endocrine neoplasia type 2B by RET mutations. , 2000, Biochemical and biophysical research communications.
[166] Z. Vajo,et al. The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans. , 2000, Endocrine reviews.
[167] G. Risbridger,et al. Discrete cell- and stage-specific localisation of fibroblast growth factors and receptor expression during testis development. , 2000, The Journal of endocrinology.
[168] M. Rothmund,et al. A RET double mutation in the germline of a kindred with FMTC. , 2000, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[169] M. Muenke,et al. Analysis of the mutational spectrum of the FGFR2 gene in Pfeiffer syndrome , 1999, Human Genetics.
[170] A. Miyauchi,et al. Two Germline Missense Mutations at Codons 804 and 806 of the RET Proto‐oncogene in the Same Allele in a Patient with Multiple Endocrine Neoplasia Type 2B without Codon 918 Mutation , 1999, Japanese journal of cancer research : Gann.
[171] M. Gonzalès,et al. Clinical variability in patients with Apert's syndrome. , 1999, Journal of neurosurgery.
[172] A. Munnich,et al. Mutations in fibroblast growth-factor receptor 3 in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosome. , 1998, American journal of human genetics.
[173] J. A. Harris,et al. Birth prevalence, mutation rate, sex ratio, parents' age, and ethnicity in Apert syndrome. , 1997, American journal of medical genetics.
[174] L. Mulligan,et al. Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation. , 1997, The Journal of clinical endocrinology and metabolism.
[175] B. Ponder,et al. Germline mutation of RET codon 883 in two cases of de novo MEN 2B , 1997, Oncogene.
[176] C. Eng,et al. Prevalence and parental origin of de novo RET mutations in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma [4] , 1997 .
[177] G M Lenoir,et al. Prevalence and parental origin of de novo RET mutations in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma. Le Groupe d'Etude des Tumeurs a Calcitonine. , 1997, American journal of human genetics.
[178] E. Zackai,et al. Genotype-phenotype correlation for nucleotide substitutions in the IgII-IgIII linker of FGFR2. , 1997, Human molecular genetics.
[179] C. Richards,et al. Relevance of RET proto-oncogene mutations in sporadic medullary thyroid carcinoma. , 1996, The Journal of clinical endocrinology and metabolism.
[180] Steven A. Wall,et al. Exclusive paternal origin of new mutations in Apert syndrome , 1996, Nature Genetics.
[181] G. Scarano,et al. Effect of paternal age in achondroplasia, thanatophoric dysplasia, and osteogenesis imperfecta. , 1995, American journal of medical genetics.
[182] P. Goodfellow,et al. Two maternally derived missense mutations in the tyrosine kinase domain of the RET protooncogene in a patient with de novo MEN 2B. , 1995, Human Molecular Genetics.
[183] D. Rimoin,et al. Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3 , 1995, Nature Genetics.
[184] I. Kaitila,et al. Achondroplasia is defined by recurrent G380R mutations of FGFR3. , 1995, American journal of human genetics.
[185] W. Reardon,et al. Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome , 1995, Nature Genetics.
[186] P. Goodfellow,et al. Parent-of-origin effects in multiple endocrine neoplasia type 2B. , 1994, American journal of human genetics.
[187] R. Brinster,et al. Spermatogenesis following male germ-cell transplantation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[188] T. van Vroonhoven,et al. Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A. , 1994, The New England journal of medicine.
[189] Arnold Munnich,et al. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia , 1994, Nature.
[190] D. Clayton,et al. Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC , 1994, Nature Genetics.
[191] B. Ponder,et al. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A , 1993, Nature.
[192] S. Kreiborg,et al. Birth prevalence study of the Apert syndrome. , 1992, American journal of medical genetics.
[193] M. Burch,et al. A clinical study of Noonan syndrome. , 1992, Archives of disease in childhood.
[194] C. Stoll,et al. Birth prevalence rates of skeletal dysplasias , 1989, Clinical genetics.
[195] N. Risch,et al. Spontaneous mutation and parental age in humans. , 1987, American journal of human genetics.
[196] M. Wigler,et al. Analysis of the transforming potential of the human H-ras gene by random mutagenesis. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[197] R. Dymock,et al. SPERMATOCYTIC SEMINOMA , 1976, The Medical journal of Australia.
[198] F Vogel,et al. Spontaneous mutation in man. , 1975, Advances in human genetics.
[199] L. Penrose. Parental age and mutation. , 1955, Lancet.